BCI
GMAB icon

Brinker Capital Investments’s Genmab GMAB Stock Holding History

Brinker Capital Investments’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$649K Sell
23,616
-439
-2% -$11.7K 0.01% 1370
2026
Q1 		$645K Buy
24,055
+156
+0.7% +$4.67K 0.01% 1350
2025
Q4 		$736K Buy
23,899
+4,206
+21% +$131K 0.01% 1404
2025
Q3 		$604K Buy
19,693
+441
+2% +$10.7K ﹤0.01% 1469
2025
Q2 		$398K Sell
19,252
-2,011
-9% -$41.3K ﹤0.01% 1585
2025
Q1 		$416K Buy
21,263
+3,887
+22% +$81.5K ﹤0.01% 1492
2024
Q4 		$363K Sell
17,376
-3,919
-18% -$86.1K ﹤0.01% 1468
2024
Q3 		$519K Buy
21,295
+112
+0.5% +$2.99K 0.01% 1324
2024
Q2 		$532K Sell
21,183
-1,251
-6% -$35.5K 0.01% 1253
2024
Q1 		$671K Buy
22,434
+2,186
+11% +$64.2K 0.01% 1158
2023
Q4 		$664K Sell
20,248
-5,873
-22% -$184K 0.01% 1102
2023
Q3 		$921K Buy
26,121
+7,322
+39% +$279K 0.01% 958
2023
Q2 		$715K Sell
18,799
-1,527
-8% -$60.9K 0.01% 1081
2023
Q1 		$767K Sell
20,326
-1,212
-6% -$46.6K 0.01% 988
2022
Q4 		$913K Sell
21,538
-498
-2% -$20.5K 0.02% 764
2022
Q3 		$708K Buy
22,036
+128
+0.6% +$4.49K 0.01% 832
2022
Q2 		$712K Sell
21,908
-1,809
-8% -$58.6K 0.01% 855
2022
Q1 		$858K Sell
23,717
-2,032
-8% -$69.7K 0.01% 857
2021
Q4 		$1.02M Sell
25,749
-348
-1% -$14.5K 0.01% 811
2021
Q3 		$1.07M Hold
26,097
– – 0.02% 752
2021
Q2 		$1.07M Buy
+26,097
New +$1.01M 0.01% 805
2021
Q1 		– Sell
-12,786
Closed -$520K – 1207
2020
Q4 		$520K Buy
+12,786
New +$478K 0.01% 827

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Brinker Capital Investments's GMAB Position: Q2 2026 in Review

Brinker Capital Investments reduced its Genmab (GMAB) stake by 1.8% in Q2 2026, selling an estimated $11.7K and leaving 23,616 shares worth $649K. The position accounts for 0.01% of the portfolio, ranked #1370.

Brinker Capital Investments first reported a position in GMAB in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.07M in Q3 2021. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Brinker Capital Investments held 23,616 shares of Genmab worth $649K as of Q2 2026.
  • Brinker Capital Investments sold 439 Genmab shares in Q2 2026, an estimated $11.7K.
  • Genmab made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1370 holding.
  • Brinker Capital Investments first reported a position in Genmab in Q4 2020 and has held it in 22 quarters since.
  • Brinker Capital Investments's Genmab position peaked at $1.07M in Q3 2021.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.